III-21," a randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of bovhyaluronidase azoximer in adult patients with pulmonary sequelae of COVID-19.

Data since the early 1900s indicate that influenza might increase the risk for cardiovascular complications. Today, we know ...

III-21," a randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of bovhyaluronidase azoximer in adult patients with pulmonary sequelae of COVID-19. Bovhyaluronidase ...

A mysterious illness in the Democratic Republic of Congo, initially feared to be "Disease X," has likely been identified as ...

BENGALURU: A study by the Indian Institute of Science (IISc) has revealed why viruses like SARS-CoV-2, which originate in ...

COLD AND FLU VIRUSES have been making people sneeze and hack for millennia. Ancient Egyptians described a flu-like illness on ...

It’s not like no one has tried. In the late ‘90s and early aughts, a now-defunct company, ViroPharma, developed an antiviral ...

SARS-CoV-2 is a positive-sense single-stranded RNA virus. It is contagious in humans and is the cause of the coronavirus disease 2019 (COVID-19). This study explores how G3BP proteins influence ...

Immutep (ASX:IMM) has announced the initiation of its TACTI-004 Phase III clinical trial, which aims to evaluate the efficacy ...

Improving indoor air quality includes increasing ventilation rates, adding high quality filters to the air handling systems, ...